Univest
Univest
  • Markets
  • 3 Chronic Therapy Brand Company, Formulations Exporter and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma

    • October 28, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Chronic Therapy Brand Company, Formulations Exporter and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma

    Chronic Brand, Export and Leader Pharma with a strong future roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Specialty Branded Generics Company, Domestic Pharma Volume Leader and Overseas Formulations Maker Stocks With a Strong Future Roadmap: Ajanta Pharma, Mankind Pharma and Marksans Pharma

    • October 28, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Specialty Branded Generics Company, Domestic Pharma Volume Leader and Overseas Formulations Maker Stocks With a Strong Future Roadmap: Ajanta Pharma, Mankind Pharma and Marksans Pharma

    Branded Generic and Formulation Exporter Stocks with a strong future roadmap: Ajanta Pharma, Mankind Pharma and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Latin America Branded Generics Seller, Over-the-Counter Formulations Exporter and Oncology and Complex Generics Maker Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma

    • October 27, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Latin America Branded Generics Seller, Over-the-Counter Formulations Exporter and Oncology and Complex Generics Maker Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma

    Emerging Market, OTC and Cancer Drug Stocks with a strong future roadmap: Caplin Point Laboratories, Marksans Pharma and Natco Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 Branded Generics Marketer, Cardiac and Gastro Brands Company and Over-the-Counter Formulations Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, JB Chemicals and Pharmaceuticals and Marksans Pharma

    • October 27, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Branded Generics Marketer, Cardiac and Gastro Brands Company and Over-the-Counter Formulations Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, JB Chemicals and Pharmaceuticals and Marksans Pharma

    Branded Generics, Cardiac and OTC Pharma Stocks with a strong future roadmap: Emcure Pharmaceuticals, JB Chemicals and Pharmaceuticals and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 Over-the-Counter Formulations Exporter, Cardiovascular and CNS Brand Leader and Contract Manufacturing Specialist Stocks With a Strong Future Roadmap: Marksans Pharma, Torrent Pharmaceuticals and Innova Captab

    • October 27, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Over-the-Counter Formulations Exporter, Cardiovascular and CNS Brand Leader and Contract Manufacturing Specialist Stocks With a Strong Future Roadmap: Marksans Pharma, Torrent Pharmaceuticals and Innova Captab

    OTC, Specialty Brand and Contract Pharma Stocks with a strong future roadmap: Marksans Pharma, Torrent Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 26 October 2026.

    read more
  • 3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma

    • October 26, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma

    Fermentation API, Contract Pharma and OTC Stocks with a strong future roadmap: Concord Biotech, Laurus Labs and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Research-Driven Contract Manufacturer, Over-the-Counter Formulations Exporter and Point-of-Care Molecular Diagnostics Maker Stocks With a Strong Future Roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics

    • October 26, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Research-Driven Contract Manufacturer, Over-the-Counter Formulations Exporter and Point-of-Care Molecular Diagnostics Maker Stocks With a Strong Future Roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics

    CDMO, OTC Pharma and Diagnostics Stocks with a strong future roadmap: Anthem Biosciences, Marksans Pharma and Molbio Diagnostics. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Research-Driven Drug Maker, Complex Generics Supplier and Over-the-Counter Medicine Exporter Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma

    • October 26, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Research-Driven Drug Maker, Complex Generics Supplier and Over-the-Counter Medicine Exporter Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma

    Branded Generics and Export Pharma Stocks with a strong future roadmap: Glenmark Pharmaceuticals, Alembic Pharmaceuticals and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Generic Pharma Exporter Stocks With a Strong Future Roadmap: Strides Pharma Science, Granules India and Marksans Pharma

    • October 7, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Generic Pharma Exporter Stocks With a Strong Future Roadmap: Strides Pharma Science, Granules India and Marksans Pharma

    Strides Pharma Science, Granules India and Marksans Pharma compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • 1
  • 2